Clorox CLX Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.19B+418% | $229M+35.5% | $169M-0.6% | $170M-25.8% | $229M-22.1% | ||
| $671M0.0% | $671M-4.6% | $703M-14.4% | $821M+37.5% | $597M-1.0% | ||
| $588M-3.3% | $608M+5.4% | $577M+10.3% | $523M— | $0— | ||
| $151M-2.6% | $155M+4.0% | $149M+5.7% | $141M-2.8% | $145M-3.3% | ||
| $23M+27.8% | $18M0.0% | $18M+20.0% | $15M-28.6% | $21M+31.3% | ||
| $489M-5.8% | $519M+3.8% | $500M+11.9% | $447M-19.2% | $553M+8.4% | ||
| $205M-7.7% | $222M-10.8% | $249M+157% | $97M-26.5% | $132M-10.2% | ||
| $2.65B+53.4% | $1.73B+1.9% | $1.7B+5.4% | $1.61B+1.1% | $1.59B-2.6% | ||
| $1.24B-1.0% | $1.25B-0.3% | $1.25B-1.3% | $1.27B+1.8% | $1.25B+0.2% | ||
| $3.04B+1.2% | $3.01B+1.8% | $2.96B+1.5% | $2.91B+1.4% | $2.87B+1.4% | ||
| $355M-3.5% | $368M+15.7% | $318M-4.5% | $333M-4.6% | $349M-3.6% | ||
| $1.23B-0.2% | $1.23B+0.3% | $1.23B-0.2% | $1.23B+0.6% | $1.22B+0.2% | ||
| $49M-9.3% | $54M-8.5% | $59M-7.8% | $64M-5.9% | $68M-6.8% | ||
| $23M+21.1% | $19M-5.0% | $20M0.0% | $20M-4.8% | $21M-4.5% | ||
| $415M-14.1% | $483M+1.5% | $476M-14.7% | $558M+3.9% | $537M-2.0% | ||
| $6.44B+14.7% | $5.61B+1.5% | $5.53B-0.6% | $5.56B+0.9% | $5.51B-1.2% | ||
| $1.48B-24.4% | $1.96B+1.6% | $1.93B+5.4% | $1.83B-9.3% | $2.02B+38.1% | ||
| $28M+3.7% | $27M0.0% | $27M0.0% | $27M0.0% | $27M-3.6% | ||
| $1.59B+418% | $307M+40.8% | $218M+5,350% | $4M-92.6% | $54M-71.4% | ||
| $85M+2.4% | $83M-6.7% | $89M+2.3% | $87M+2.4% | $85M+4.9% | ||
| $3.16B+34.4% | $2.35B+5.1% | $2.23B+16.4% | $1.92B-11.0% | $2.16B+24.6% | ||
| $2.49B0.0% | $2.49B0.0% | $2.49B0.0% | $2.48B0.0% | $2.48B0.0% | ||
| $323M-5.3% | $341M+19.2% | $286M-6.2% | $305M-5.3% | $322M-5.0% | ||
| $356M-7.5% | $385M+5.5% | $365M+4.0% | $351M+2.9% | $341M-61.3% | ||
| $6.34B+13.7% | $5.58B+3.5% | $5.39B+6.1% | $5.08B-4.6% | $5.32B-2.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 750M0.0% | 750M0.0% | 750M0.0% | 750M0.0% | 750M0.0% | ||
| $1.32B+0.8% | $1.3B-1.7% | $1.33B+0.5% | $1.32B+1.2% | $1.3B+1.3% | ||
| $223M+17.4% | $190M-5.0% | $200M-53.7% | $432M+336% | $99M+45.6% | ||
| -$152M+4.4% | -$159M+3.6% | -$165M-5.1% | -$157M+10.8% | -$176M+2.8% | ||
| $1.58B-0.4% | $1.59B+5.1% | $1.51B+7.8% | $1.4B+5.5% | $1.33B-1.1% | ||
| $159M-0.6% | $160M0.0% | $160M-0.6% | $161M-1.2% | $163M+0.6% | ||
| -$67M+46.4% | -$125M-468% | -$22M-107% | $321M+1,089% | $27M+166% | ||
| $6.44B+14.7% | $5.61B+1.5% | $5.53B-0.6% | $5.56B+0.9% | $5.51B-1.2% | ||
| $489M-5.8% | $519M+3.8% | $500M+11.9% | $447M-19.2% | $553M+8.4% | ||
| $151M-2.6% | $155M+4.0% | $149M+5.7% | $141M-2.8% | $145M-3.3% | ||
| $75M-10.7% | $84M-6.7% | $90M+12.5% | $80M-4.8% | $84M0.0% | ||
| $415M-14.1% | $483M+1.5% | $476M-14.7% | $558M+3.9% | $537M-2.0% | ||
| $355M-3.5% | $368M+15.7% | $318M-4.5% | $333M-4.6% | $349M-3.6% | ||
| $355M-3.5% | $368M+15.7% | $318M-4.5% | $333M-4.6% | $349M-3.6% | ||
| $415M-14.1% | $483M+1.5% | $476M-14.7% | $558M+3.9% | $537M-2.0% | ||
| $49M-9.3% | $54M-8.5% | $59M-7.8% | $64M-5.9% | $68M-6.8% | ||
| $502M0.0% | $502M0.0% | $502M0.0% | $502M+0.2% | $501M0.0% | ||
| $355M-3.5% | $368M+15.7% | $318M-4.5% | $333M-4.6% | $349M-3.6% | ||
| $415M-14.1% | $483M+1.5% | $476M-14.7% | $558M+3.9% | $537M-2.0% | ||
| $28M+3.7% | $27M0.0% | $27M0.0% | $27M0.0% | $27M-3.6% | ||
| $0— | $0— | $0— | —— | $0— | ||
| $1.48B-24.4% | $1.96B+1.6% | $1.93B+5.4% | $1.83B-9.3% | $2.02B+38.1% | ||
| 18,500,000,000%-1,300,000,000% | 19,800,000,000%+1,900,000,000% | 17,900,000,000%-5,700,000,000% | 23,600,000,000%+900,000,000% | 22,700,000,000%+900,000,000% | ||
| $4.49B+39.4% | $3.22B+4.5% | $3.08B+5.6% | $2.92B-1.0% | $2.94B-4.8% | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | ||
| 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $1.32B+0.8% | $1.3B-1.7% | $1.33B+0.5% | $1.32B+1.2% | $1.3B+1.3% | ||
| $131M0.0% | $131M0.0% | $131M0.0% | $131M0.0% | $131M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| $28M+3.7% | $27M0.0% | $27M0.0% | $27M0.0% | $27M-3.6% | ||
| $1.59B+418% | $307M+40.8% | $218M+5,350% | $4M-92.6% | $54M-71.4% | ||
| $10.0% | $10.0% | $10.0% | $10.0% | $10.0% | ||
| $750M0.0% | $750M0.0% | $750M0.0% | $750M0.0% | $750M0.0% | ||
| $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | ||
| $120.92M0.0% | $120.89M-0.7% | $121.78M-0.7% | $122.69M-0.5% | $123.25M+0.1% | ||
| $23M+21.1% | $19M-5.0% | $20M0.0% | $20M-4.8% | $21M-4.5% | ||
| $0-100% | $1M— | $0-100% | $2M— | $0— | ||
| $588M-3.3% | $608M+5.4% | $577M+10.3% | $523M-17.6% | $635M+7.3% | ||
| $18M0.0% | $18M-10.0% | $20M— | —— | $18M0.0% | ||
| $0— | $0— | $0— | —— | $0— | ||
| $159M-0.6% | $160M0.0% | $160M-0.6% | $161M-1.2% | $163M+0.6% | ||
| $10.0% | $10.0% | $10.0% | $10.0% | $10.0% | ||
| $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $9.82M-0.3% | $9.85M+9.9% | $8.97M+11.4% | $8.05M+7.4% | $7.49M-1.3% | ||
| —— | $476M0.0% | $476M0.0% | $476M— | —— | ||
| —— | $476M-2.5% | $488M-2.6% | $501M-2.7% | $515M-0.4% | ||
| 4%— | —— | —— | 4.6%0.0% | 4.6%-0.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Clorox's total assets?
- Clorox (CLX) holds $6.4B in total assets, up 16.8% year over year.
- How much debt does Clorox have?
- Clorox carries $4.5B in total debt against -$67.0M of shareholders' equity, a debt-to-equity ratio of 9.08.
- How much cash does Clorox have?
- Clorox holds $1.2B in cash and equivalents.
- Can Clorox cover its short-term obligations?
- Its current ratio is 0.84 — current liabilities exceed current assets.
- Where does Clorox's balance sheet data come from?
- Every line is extracted from Clorox's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
